OrbiMed’s Spyre Therapeutics SYRE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-71,889	Closed	-$521K	–	127
2023 Q1	$521K	Hold	71,889	–	–	0.01%	114
2022 Q4	$809K	Hold	71,889	–	–	0.02%	112
2022 Q3	$945	Hold	71,889	–	–	0.02%	126
2022 Q2	$908	Sell	71,889 -46,356	-39%	-$586	0.02%	136
2022 Q1	$6.8M	Hold	118,245	–	–	0.11%	111
2021 Q4	$14M	Sell	118,245 -42,376	-26%	-$5.03M	0.18%	102
2021 Q3	$31.9M	Hold	160,621	–	–	0.35%	74
2021 Q2	$27.9M	Hold	160,621	–	–	0.28%	84
2021 Q1	$31.8M	Hold	160,621	–	–	0.3%	80
2020 Q4	$31.6M	Hold	160,621	–	–	0.28%	80
2020 Q3	$28.5M	Hold	160,621	–	–	0.36%	72
2020 Q2	$37.1M	Buy	160,621 +46,000	+40%	+$10.6M	0.52%	55
2020 Q1	$13.4M	Hold	114,621	–	–	0.22%	78
2019 Q4	$21.9M	Hold	114,621	–	–	0.31%	63
2019 Q3	$22M	Buy	114,621 +28,000	+32%	+$5.38M	0.42%	56
2019 Q2	$14.8M	Hold	86,621	–	–	0.23%	77
2019 Q1	$17.4M	Hold	86,621	–	–	0.27%	77
2018 Q4	$16.2M	Hold	86,621	–	–	0.3%	74
2018 Q3	$20.7M	Buy	86,621 +12,000	+16%	+$2.87M	0.25%	88
2018 Q2	$19.7M	Buy	74,621 +15,840	+27%	+$4.19M	0.24%	92
2018 Q1	$14.6M	Hold	58,781	–	–	0.18%	92
2017 Q4	$7.95M	Hold	58,781	–	–	0.1%	108
2017 Q3	$7.24M	Hold	58,781	–	–	0.07%	111
2017 Q2	$5.66M	Hold	58,781	–	–	0.06%	108
2017 Q1	$10.9M	Buy	58,781 +4,372	+8%	+$814K	0.12%	92
2016 Q4	$5.92M	Hold	54,409	–	–	0.08%	105
2016 Q3	$8.72M	Hold	54,409	–	–	0.1%	100
2016 Q2	$6.61M	Buy	+54,409	New	+$6.61M	0.07%	103